Poseida Therapeutics Inc (NQ: PSTX )

2.470 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
October 16, 2013
Form 8-K
Source: SEC/Edgar
August 08, 2013
Form 424B3
Source: SEC/Edgar
May 21, 2013
Form EFFECT
Source: SEC/Edgar
May 08, 2013
Form POS AM
Source: SEC/Edgar
May 07, 2013
Form 10-K/A
Source: SEC/Edgar
April 29, 2013
Form CT ORDER
Source: SEC/Edgar
April 15, 2013
Form 8-K
Source: SEC/Edgar
March 25, 2013
Form S-8
Source: SEC/Edgar
March 25, 2013
Form 424B3
Source: SEC/Edgar
March 21, 2013
Form 424B3
Source: SEC/Edgar
March 21, 2013
Form 8-K
Source: SEC/Edgar
March 18, 2013
Form 8-K
Source: SEC/Edgar
February 11, 2013
Form 8-K
Source: SEC/Edgar
December 05, 2012
Form 424B3
Source: SEC/Edgar
December 03, 2012
Form 424B3
Source: SEC/Edgar
December 03, 2012
Form 8-K
Source: SEC/Edgar
October 03, 2012
Form 8-K
Source: SEC/Edgar
September 26, 2012
Form 8-K
Source: SEC/Edgar
August 29, 2012
Form 424B3
Source: SEC/Edgar
August 23, 2012
Form 424B3
Source: SEC/Edgar
August 22, 2012
Form 8-K
Source: SEC/Edgar
July 23, 2012
Form EFFECT
Source: SEC/Edgar
July 15, 2012
Form S-1
Source: SEC/Edgar
July 01, 2012
Form DEF 14A
Source: SEC/Edgar
June 26, 2012
Form PRE 14A
Source: SEC/Edgar
June 12, 2012
Form 8-K
Source: SEC/Edgar
June 04, 2012
Form D
Source: SEC/Edgar
June 03, 2012
Form 8-K
Source: SEC/Edgar
May 21, 2012
Form 8-K
Source: SEC/Edgar
May 21, 2012
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.